Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies
Saved in:
Main Authors: | Martin K. H. Ho, Araniy Santhireswaran, Tara Gomes, Muhammad Mamdani, Mina Tadrous |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12310029/?tool=EBI |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies.
by: Martin K H Ho, et al.
Published: (2025-01-01) -
Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.
by: Carolyn Tieu, et al.
Published: (2018-01-01) -
The safety of biological preparations. Part 2. Safety issues of biosimilars
by: A. A. Soldatov, et al.
Published: (2018-02-01) -
SAFETY STUDY OF ROMIPLOSTIM BIOSIMILAR
by: A. N. Afanasyeva, et al.
Published: (2022-10-01) -
Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products
by: V. D. Gusarova, et al.
Published: (2019-03-01)